Opinion|Videos|August 21, 2024
CML Treatment: Scenarios that Necessitate Switching Therapy
Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.
Advertisement
Episodes in this series
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions:
- In which scenarios do you consider switching CML therapies, and how do you approach that conversation with patients? How does the patient experience change when switching therapies?
Advertisement
Related to this article
Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Sunvozertinib Now Available in US for Pretreated EGFR Exon 20+ NSCLC
2
Male Breast Cancer: Managing Endocrine Therapy and Survivorship Care
3
What Oncology Nurses Need to Know About ADCs in Breast Cancer
4
FDA Grants Traditional Approval to Pembrolizumab in TMB-H Solid Tumors
5